QYH Biotech Co., Ltd. (QYH) is mainly engaged in the production, sales, research and development, technical services, project investment and import and export trade of veterinary biological products and diagnostic reagents.

QYH is designated by the MARA to produce vaccines for highly pathogenic avian influenza and other major animal diseases.

QYH has 3 production sites, 21 GMP production lines, 200+ veterinary biological products of different pack sizes, with an annual production capacity of nearly 21 billion doses. The products have been exported to more than 20 countries.

As one of the top 10 veterinary biological products enterprises in China, QYH has continuously adhered to scientific and technological innovation in the past years, and is committed to becoming a leader in China's poultry biological products industry.